Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 2361 of 6372
-
Can a wearable glucose monitor improve daily diabetes care? a 5,000-Person study seeks answers
Knowledge-focused Ongoing"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"
Sponsor: DexCom, Inc. • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New MRI scan could replace painful liver biopsies for MASH patients
Diagnosis By invitation onlyThe goal of this study is to assess the value of liver dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and texture analysis post gadopiclenol for liver fibrosis staging, in comparison with MR elastography, T1 mapping, ultrasound elastography and blood tests in 50 i…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New shot aims to tame high cholesterol and triglycerides
Disease control OngoingA Phase 2 in Patients With Mixed Dyslipidemia
Phase 2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New gel made from platelets shows promise for healing diabetic foot sores
Disease control CompletedThis is a Phase 2a Multi-Center, Prospective, Randomized, Controlled Study aimed to evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic Foot Ulcers (DFU)
Phase 2 • Sponsor: Rion Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New heart device tested for long-term relief from AFib
Disease control Recruiting nowObservational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospect…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Generic fertility drug could cut IVF costs without sacrificing success
Disease control Recruiting nowThe goal of this clinical trial is to compare the clinical outcomes using different cetrorelix acetate in the context of a GnRH antagonist protocol for ovarian stimulation in women undergoing IVF or intracytoplasmic sperm injection(ICSI) treatment.The main question it aims to ans…
Sponsor: Northwest Women's and Children's Hospital, Xi'an, Shaanxi • Aim: Disease control
Last updated Jun 26, 2026 19:11 UTC
-
Could a single pill transform heart failure care for underserved patients?
Disease control CompletedA novel four-drug regimen for heart failure with reduced ejection fraction (HFrEF) extends patients' life expectancy by an average of 6 years compared to traditional therapies, in addition to improving quality of life. Unfortunately, uptake of this complex multi-drug regimen has …
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for patients with hard-to-treat pituitary tumors
Disease control Recruiting nowThe researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist therapy. Another purpose of this study is to find out whether pasireotide is a safe treatment for people with prolactino…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New DNA method may spot hidden joint infections faster
Diagnosis CompletedThe objectiveof this of a prospective, multicentre study is to evaluate the performance of shotgun metagenomics in the diagnosis of chronic Prosthetic joint infection (PJI) in comparison with the adapted MSIS diagnostic score.. The main questions it aims to answer are: * To eva…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Heart clip aims to cut stroke risk in surgery patients
Disease control OngoingThe purpose of this study is to collect post-market clinical evidence on performance and clinical outcomes of the Penditure™ Left Atrial Appendage (LAA) Exclusion System in subjects undergoing concomitant cardiac surgery.
Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a tailored dialysis schedule be safer for kidney patients?
Disease control Recruiting nowThis study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients with incident kidney dysfunction requiring dialysis and residual kidney function. The study will enroll 350 patients on ch…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New app aims to tackle diabetes stress in School-Age children
Symptom relief Recruiting nowThis R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in famili…
Sponsor: Nemours Children's Clinic • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New balloon treatment may shorten blood thinner use for heart patients
Disease control OngoingPost-market, prospective, observational, multicenter, non-intervention study, to demonstrate the effectiveness of drug-coated ballon (DCB)therapy in real-world patients with small native vessel coronary artery disease, and to demonstrate the safety of short dual antiplatelet ther…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spanish study checks Real-World use of MS drug ofatumumab
Disease control CompletedThis was a non-interventional, cross-sectional, multicentric, and nationwide study, based on primary and secondary data collection.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Brain surgery breakthrough? diaphragm zap may cut delirium risk
Disease control CompletedThis prospective, single-center, randomized controlled clinical trial aims to investigate the impact of intraoperative phrenic nerve stimulation (i.e., diaphragmatic neuromodulation) on postoperative complications in neurosurgical patients. The primary objective is to assess the …
Sponsor: Beijing Sanbo Brain Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:13 UTC
-
Spinal zaps may help failed back surgery patients walk again
Symptom relief Recruiting nowThe purpose of this study is to explore the changes in objective walking parameters induced by medullary stimulation in patients with Fail Back Surgery Syndrome, after chronic stimulation, in comparison with preoperative condition.
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New combo drug CagriSema shows promise in curbing appetite and food intake
Symptom relief CompletedThis research study tests if CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight. Participant will either get CagriSema (active medicine) or placebo (a dummy medicine), which has no effect on the body. The treatment participant…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could gut bacteria predict infection risk in lymphedema?
Knowledge-focused Recruiting nowLymphedema is a chronic and progressive disease of the lymphatic vessels which affects about 300 million people worldwide. Patients may experience recurrent soft tissue infection of the limb affected by lymphedema, in terms of erysipelas, lymphangitis or cellulitis. No previous s…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New scan lights up hidden gut tumors
Diagnosis CompletedThis is a single-arm imaging study using DOTATOC peptide, labelled with the Gallium (68Ga) tracer.
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Gout showdown: which treatment strategy wins?
Disease control Recruiting nowThe TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most beneficial for a patient-centered gout outcomes, as well as relevant cardiovascular-m…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC